ganirelix acetate
Generic: ganirelix acetate
Labeler: qilu pharmaceutical co., ltd.Drug Facts
Product Profile
Brand Name
ganirelix acetate
Generic Name
ganirelix acetate
Labeler
qilu pharmaceutical co., ltd.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ganirelix acetate 250 ug/.5mL
Manufacturer
Identifiers & Regulatory
Product NDC
67184-0574
Product ID
67184-0574_edcb57c8-5b08-4076-b67c-93d6d610525d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA218855
Listing Expiration
2026-12-31
Marketing Start
2025-05-15
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
671840574
Hyphenated Format
67184-0574
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ganirelix acetate (source: ndc)
Generic Name
ganirelix acetate (source: ndc)
Application Number
ANDA218855 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 ug/.5mL
Packaging
- 1 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "edcb57c8-5b08-4076-b67c-93d6d610525d", "openfda": {"upc": ["0367184057412"], "unii": ["56U7906FQW"], "rxcui": ["855200"], "spl_set_id": ["440f6d67-f02e-4407-8830-39c394e25e5d"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS", "package_ndc": "67184-0574-1", "marketing_start_date": "20250515"}], "brand_name": "Ganirelix Acetate", "product_id": "67184-0574_edcb57c8-5b08-4076-b67c-93d6d610525d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased GnRH Secretion [PE]", "Gonadotropin Releasing Hormone Receptor Antagonist [EPC]", "Gonadotropin Releasing Hormone Receptor Antagonists [MoA]"], "product_ndc": "67184-0574", "generic_name": "Ganirelix Acetate", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ganirelix Acetate", "active_ingredients": [{"name": "GANIRELIX ACETATE", "strength": "250 ug/.5mL"}], "application_number": "ANDA218855", "marketing_category": "ANDA", "marketing_start_date": "20250515", "listing_expiration_date": "20261231"}